<DOC>
	<DOCNO>NCT02312154</DOCNO>
	<brief_summary>IMPORTANCE Skin rejuvenation achieve effectively safely injection stabilize hyaluronic acid ( HA ) -based gel nonanimal origin ( NASHA ) injection use stamp-type electronic multineedle injector . OBJECTIVE To determine efficacy safety NASHA use stamp-type electronic multineedle injector , change skin physiology occur earlier previous trial . DESIGN , SETTING , AND PARTICIPANTS Twenty-five patient recruit single-center , evaluator-blinded , prospective , balance ( 1:1 ) , split-face randomized clinical trial.One dermatologist blind treatment side evaluate skin hydration , melanin content , erythema , elasticity cheek use corneometer , mexameter , reviscometer , respectively , follow-up visit ( 0 , 1 , 2 , 4 , 8 , 12 week postinjection ) . The subject two independent investigator assess clinical improvement use Global Aesthetic Improvement Scale ( GAIS ) every visit . Twenty-four participant complete study , participant withdraw due adverse effect . INTERVENTIONS Each participant submit single treatment NASHA injection one side low cheek . The cheek side treatment apply choose randomly .</brief_summary>
	<brief_title>Changing Skin Physiology After Microdroplet Placement Stabilized Hyaluronic Acid Aging Faces</brief_title>
	<detailed_description>Twenty-five patient recruit single-center , evaluator-blinded , prospective , balance ( 1:1 ) , split-face randomized clinical trial . Twenty-four participant complete study , participant withdraw due adverse effect . Each participant submit single treatment NASHA injection one side low cheek . One dermatologist blind treatment side evaluate skin hydration , melanin content , erythema , elasticity cheek use corneometer , mexameter , reviscometer , respectively , follow-up visit ( 0 , 1 , 2 , 4 , 8 , 12 week postinjection ) . The subject two independent investigator assess clinical improvement use Global Aesthetic Improvement Scale ( GAIS ) every visit . Adverse event self-reported patient complete questionnaire .</detailed_description>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Healthy people older 25 year know hypersensitivity HA , active skin disease , autoimmune disorder , significant renal , hepatic , medical disease</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>